Raia Drogasil S.A.
RADLY
$3.56
$0.2597.86%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.83% | -6.59% | -4.29% | 1.28% | 9.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.83% | -6.59% | -4.29% | 1.28% | 9.03% |
| Cost of Revenue | 3.88% | -5.89% | -3.64% | 1.44% | 10.05% |
| Gross Profit | 0.40% | -8.30% | -5.80% | 0.89% | 6.73% |
| SG&A Expenses | 0.63% | -4.46% | -5.63% | -2.38% | 8.31% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -88.52% | -5,434.94% | 140.85% | 149.63% | 444.98% |
| Total Operating Expenses | 2.98% | -5.92% | -2.94% | 1.30% | 9.73% |
| Operating Income | 0.66% | -17.62% | -24.79% | 0.87% | 0.19% |
| Income Before Tax | -11.57% | -39.48% | -20.00% | 28.49% | -5.09% |
| Income Tax Expenses | -82.10% | -65.57% | -442.88% | 165.86% | 13.12% |
| Earnings from Continuing Operations | 7.15% | -27.78% | 6.00% | 11.24% | -8.98% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -302.91% | 82.86% | 100.59% | 19.08% | 60.37% |
| Net Income | 5.31% | -26.17% | 13.04% | 11.76% | -8.23% |
| EBIT | 0.66% | -17.62% | -24.79% | 0.87% | 0.19% |
| EBITDA | 2.15% | -14.98% | -20.61% | -0.56% | 0.17% |
| EPS Basic | 83.11% | -26.09% | 17.59% | 14.38% | -46.32% |
| Normalized Basic EPS | 49.71% | -28.02% | -26.61% | 11.50% | -40.75% |
| EPS Diluted | 82.19% | -25.55% | 17.59% | 13.75% | -46.32% |
| Normalized Diluted EPS | 48.55% | -27.32% | -26.61% | 10.62% | -40.75% |
| Average Basic Shares Outstanding | -42.58% | -0.15% | -3.84% | -2.33% | 71.24% |
| Average Diluted Shares Outstanding | -42.27% | -0.80% | -3.84% | -1.74% | 71.24% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 0.13% | -0.40% | -0.26% | 1.89% | 0.09% |